Yufang Shi

Yufang Shi


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in Cell Death & Differentiation
Verified
Journal Article
Open access
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi
IVIlio Vitale
Ilio Vitale
SAStuart A. Aaronson
Stuart A. Aaronson
JAJohn M. Abrams
John M. Abrams
DADieter Adam
Dieter Adam
Guido KroemerGuido Kroemer
Guido Kroemer
Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.

15 July 2011 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
LGL Galluzzi
L Galluzzi
IVIlio Vitale
Ilio Vitale
JAJ M Abrams
J M Abrams
EAE S Alnemri
E S Alnemri
EBE H Baehrecke
E H Baehrecke
Guido KroemerGuido Kroemer
Guido Kroemer

1 July 2006 in Cancer Cell
Verified
Journal Article
Closed access
KDKurt Degenhardt
Kurt Degenhardt
RMRobin Mathew
Robin Mathew
BBBrian Beaudoin
Brian Beaudoin
KBKevin Bray
Kevin Bray
DADiana Anderson
Diana Anderson
EWEileen White
Eileen White

1 February 2008 in Cell Stem Cell
Verified
Journal Article
Closed access
GRGuangwen Ren
Guangwen Ren
LZLiying Zhang
Liying Zhang
XZXin Zhao
Xin Zhao
GXGuangwu Xu
Guangwu Xu
YZYingyu Zhang
Yingyu Zhang
YSYufang Shi
Yufang Shi

20 October 2014 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YWYing Wang
Ying Wang
XCXiaodong Chen
Xiaodong Chen
WCWei Cao
Wei Cao
YSYufang Shi
Yufang Shi

12 February 2016 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
QCQ Chen
Q Chen
PSP Shou
P Shou
CZC Zheng
C Zheng
MJM Jiang
M Jiang
GCG Cao
G Cao
YSYufang Shi
Yufang Shi
Mesenchymal stem cells (MSCs), a non-hematopoietic stem cell population first discovered in bone marrow, are multipotent cells capable of differentiating into mature cells of several mesenchymal tissues, such as fat and bone. As common progenitor cells of adipocytes and osteoblasts, MSCs are delicately balanced for their differentiation commitment. Numerous in vitro investigations have demonstrated that fat-induction factors inhibit osteogenesis, and, conversely, bone-induction factors hinder adipogenesis. In fact, a variety of external cues contribute to the delicate balance of adipo-osteogenic differentiation of MSCs, including chemical, physical, and biological factors. These factors trigger different signaling pathways and activate various transcription factors that guide MSCs to commit to either lineage. The dysregulation of the adipo-osteogenic balance has been linked to several pathophysiologic processes, such as aging, obesity, osteopenia, osteopetrosis, and osteoporosis. Thus, the regulation of MSC differentiation has increasingly attracted great attention in recent years. Here, we review external factors and their signaling processes dictating the reciprocal regulation between adipocytes and osteoblasts during MSC differentiation and the ultimate control of the adipo-osteogenic balance.